AEM (SGX:AWX)’s FY20 revenue guidance was 4-11% higher than our forecast.
We believe that Intel’s pivot to gain share in adjacent markets may expand the wallet size for HDMT TH. We also view the acquisition of Mu-TEST positively, as this allows AEM to provide end-to-end SLT solutions through AMPS.
ROE-g/COE-g Target Price is raised, as we roll forward to 3.8x blended FY20-21E (from 4.1x blended FY19-20E previously).
BUY.
Positive Surprise for FY20E Revenue Guidance
Our updated FY20E revenue is near the mid-point of the guided SGD330- 350m. Drivers are
sustained momentum from its key customer, which based on common market knowledge, is identified to be Intel; and
rising contributions from other initiatives.
If the sanguine outlook persists into 2H20, we do not rule out positive guidance revisions, which would be a catalyst, in our view. This is on account that
current order book already forms around 70% of full year revenue guidance;
and that the order lead time for HDMT TH is around 5 months.
Key risk is if we have overestimated profitability.
New Trends at Intel a Boon for AEM Long Term
To capture 5G and AI opportunities, Intel is pivoting to gain share in adjacent markets. AEM should benefit from this as:
this may widen the wallet size for HDMT TH over time; and
AEM should be continually plugged in to the R&D efforts of the customer, as each new chip tested on HDMT requires a customised kit.
Separately, we understand that the hybrid equipment, to be commercialised this year, focuses on burn-in test for Intel’s Foveros 3D stacked chips.
Buys Mu-TEST to Enhance AMPS Proposition
We believe the acquisition of France-based Mu-TEST enhances AMPS’ value proposition, as AEM is now able to provide full SLT solutions (test handler and tester). Mu-TEST’s proprietary FPGA-based technology is aimed at mid and high-end ICs, and is generally applicable for SoCs, digital ICs, memories and sensors.
Mu-TEST’s solutions are highly customisable and we understand can be easily integrated with AMPS handlers based on customers’ requirements.
Revising Up FY20-21E Forecasts
We raise FY20-21E EPS by 11-16% following AEM’s guidance update for FY20. We have also fine-tuned other line items such as gross margin and staff cost assumptions. Capex guidance of SGD4m is comparable to the SGD3-4m it guided in FY19E. Click on view full report button below for complete analysis.
Our ROE-g/COE-g Target Price is based on 3.8x blended FY20-21E P/B (rolled forward from 4.1x blended FY19-20E P/B). This is in turn based on 34.7% average FY20-21E ROE, COE of 10.6% and LTG of 2%.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....